This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Takano, R. Articles by Kyogoku, M. Search for Related Content PubMed PubMed Citation Articles by Takano, R. Articles by Kyogoku, M.

American Journal of Pathology, Vol 137, 1007-1011, Copyright © 1990 by American Society for Investigative Pathology

REGULAR ARTICLES

Increase of beta 1-6-branched oligosaccharides in human esophageal carcinomas invasive against surrounding tissue in vivo and in vitro

R Takano, M Nose, T Nishihira and M Kyogoku
Department of Pathology, Tohoku University School of Medicine, Sendai, Japan.

The -GlcNAc beta 1-6Man- (beta 1-6) branched N-glycosidic oligosaccharides expressed on tumor cells have been found to contribute to malignant and metastatic potential in experimental tumor models. Phaseolus vulgaris leukoagglutinin (L-PHA) requires the beta 1-6-linked lactosamine antenna for high-affinity binding and was used histochemically to characterize the distribution of these sugar structures in human esophageal squamous cell carcinomas from 42 patients. Leukoagglutinin-reactive carcinoma cells in the invasive tumors were distributed predominantly on the outer surface of the tumor adjacent to the surrounding tissue. Furthermore, when TE 1 cells, a human esophageal squamous cell carcinoma line, were cultured in a collagen gel matrix to obtain colonies in a three-dimensional form, these colonies exhibited high affinity for L-PHA binding only in the outer cell layer facing the collagen matrix, unrelated to the cell growth cycle. These findings suggest that the increase in beta 1-6- branched oligosaccharides in esophageal carcinomas is an important trait of the tumor in the invasion into the surrounding tissue.

This article has been cited by other articles:

				L. W. Wattenberg An interlocker concept of carcinogenesis. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1425 - 1426. [Abstract] [Full Text] [PDF]

				H. Ishimura, T. Takahashi, H. Nakagawa, S.-I. Nishimura, Y. Arai, Y. Horikawa, T. Habuchi, E. Miyoshi, A. Kyan, S. Hagisawa, et al. N-Acetylglucosaminyltransferase V and {beta}1-6 Branching N-Linked Oligosaccharides Are Associated with Good Prognosis of Patients with Bladder Cancer Clin. Cancer Res., April 15, 2006; 12(8): 2506 - 2511. [Abstract] [Full Text] [PDF]

				H. Dosaka-Akita, E. Miyoshi, O. Suzuki, T. Itoh, H. Katoh, and N. Taniguchi Expression of N-Acetylglucosaminyltransferase V Is Associated with Prognosis and Histology in Non-Small Cell Lung Cancers Clin. Cancer Res., March 1, 2004; 10(5): 1773 - 1779. [Abstract] [Full Text] [PDF]

				B. Korczak, T. Le, S. Elowe, A. Datti, and J. W. Dennis Minimal catalytic domain of N-acetylglucosaminyltransferase V Glycobiology, June 1, 2000; 10(6): 595 - 599. [Abstract] [Full Text] [PDF]

				K. Murata, E. Miyoshi, M. Kameyama, O. Ishikawa, T. Kabuto, Y. Sasaki, M. Hiratsuka, H. Ohigashi, S. Ishiguro, S. Ito, et al. Expression of N-Acetylglucosaminyltransferase V in Colorectal Cancer Correlates with Metastasis and Poor Prognosis Clin. Cancer Res., May 1, 2000; 6(5): 1772 - 1777. [Abstract] [Full Text]